More and more evidence suggested that abnormal METTL3-mediated m6A levels are involved in the malignant progression of lung cancer through the different molecular mechanisms, including angiogenesis, invasion, proliferation, metastasis, glycolysis, drug resistance, tumor environment and cancer stem cells 6-10. The gene discussed is METTL3; the disease is lung carcinoma.